The biotech industry is ripe with great investment opportunities due to technological advancements such as artificial ...

Imagine a breakthrough in cancer treatment where only malignant cells are targeted, sparing healthy host cells; or patients ...

D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate ...

New 12-month data on the first three adult OPGx-LCA5 patients to be presented at a major medical conference in Q2 2025 FDA meeting scheduled in March 2025 to discuss Phase 3 trial design and ...

The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including ...

Using protein structure prediction tools, researchers have uncovered receptor structure-function relationships to improve ...

Researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin. One day, researchers want to use switches of this kind to ...

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin.

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...

Researchers have developed a new, highly effective “gene switch” to deliver targeted cell therapy. The ETH Zurich team states that this cell therapy has the potential to offer a more precise and ...

Researchers developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic ...

Passage Bio is outsourcing future analytical testing services in a cost-cutting move that will further cut its workforce, a ...